By Counterforce Health Team in Chenodal (chenodiol) —

Getting Chenodal (Chenodiol) Covered by Blue Cross Blue Shield in Illinois: Complete PA Guide with Appeals Process

Answer Box: How to Get Chenodal Covered by Blue Cross Blue Shield in Illinois

Fastest path to approval: Have your gastroenterologist submit a prior authorization with imaging showing radiolucent gallstones, documentation of surgical risk, and evidence of ursodiol failure/contraindication. Blue Cross Blue Shield of Illinois typically requires these three elements for Chenodal approval. If denied, you have 30 days to request external review through the Illinois Department of Insurance. Start today: Call BCBS member services to confirm your plan's PA requirements and download the formulary exception form.

Table of Contents

  1. Patient Profile: Who Gets Approved
  2. Pre-Authorization Preparation
  3. Submission Process
  4. Initial Outcome: Approval or Denial
  5. Appeals Process
  6. Resolution and Approval Terms
  7. What We'd Do Differently
  8. Forms and Templates
  9. FAQ
  10. Sources and Further Reading

Patient Profile: Who Gets Approved

Sarah, a 68-year-old Illinois resident with Blue Cross Blue Shield through her employer, represents a typical Chenodal approval case. She has symptomatic radiolucent gallstones but can't undergo surgery due to severe cardiac disease and previous anesthesia complications.

Her qualifying factors:

  • Imaging confirming radiolucent (non-calcified) cholesterol gallstones
  • Well-functioning gallbladder on ultrasound
  • High surgical risk documented by cardiologist
  • Failed 6-month ursodiol trial with documented intolerance
  • Recurrent biliary colic requiring ER visits

Treatment goals: Dissolve gallstones over 12-18 months while avoiding high-risk surgery. Her gastroenterologist plans monthly liver function monitoring and expects partial dissolution within 9 months based on stone characteristics.

From our advocates: We've seen the strongest approvals when patients have clear documentation of surgical contraindications from multiple specialists. A cardiologist's letter stating "prohibitive anesthesia risk" carries more weight than a general "high risk" assessment. This specific language often tips denials toward approvals.

Pre-Authorization Preparation

Essential Documentation Checklist

Imaging Requirements:

  • Recent ultrasound (within 6 months) explicitly stating "radiolucent cholesterol gallstones"
  • Report confirming "well-opacifying gallbladder" with normal contractility
  • CT or oral cholecystography if stones aren't clearly characterized on ultrasound

Clinical Documentation:

  • Gastroenterologist consultation note with treatment plan
  • Surgical risk assessment from cardiologist, pulmonologist, or anesthesiologist
  • Documentation of symptomatic disease (biliary colic, nausea, ER visits)
  • Liver function tests within normal limits

Prior Therapy Records:

  • Ursodiol trial documentation: dates, doses, duration, outcomes
  • Specific reasons for discontinuation (ineffective vs. adverse effects)
  • Any other bile acid therapy attempts with results

Medical Necessity Letter Components

Your gastroenterologist should include:

  1. Diagnosis: ICD-10 codes for gallstones (K80.20) plus surgical risk factors
  2. Clinical rationale: Why surgery isn't appropriate and medical dissolution is indicated
  3. Prior therapies: Documented ursodiol failure or contraindication
  4. Treatment plan: Chenodal dosing, monitoring schedule, success metrics
  5. Guidelines support: Reference to FDA labeling for radiolucent stones in surgical candidates

Submission Process

Blue Cross Blue Shield Illinois Requirements

BCBS Illinois uses Prime Therapeutics for pharmacy benefits management. Chenodal typically requires prior authorization across most commercial plans.

Step-by-Step Submission:

  1. Verify coverage via the BCBS Illinois provider portal or member services (verify current link)
  2. Download forms from the Prime Therapeutics formulary exception section
  3. Complete PA request with all supporting documentation
  4. Submit via fax or online portal (confirm current submission method)
  5. Track status through provider portal or by calling PA department

Required Forms

For commercial plans: "Formulary Exception Physician Form" - must be completed by prescriber only. The form requires:

  • Member demographics and plan information
  • Requested drug details (Chenodal, strength, dosing)
  • ICD-10 diagnosis codes
  • Previously tried medications with dates and outcomes
  • Clinical justification for exception

Initial Outcome: Approval or Denial

Typical Timeline

  • Standard review: 72 hours for most commercial plans
  • Expedited review: 24 hours if delay could seriously jeopardize health
  • Decision notification: Via fax to prescriber and letter to member

Common Denial Reasons

Denial Reason Documentation Fix Success Rate
"Not radiolucent stones" Explicit radiology language, CT confirmation High
"No surgical contraindication" Specialist risk assessment letter High
"Step therapy not met" Ursodiol trial records with dates/outcomes Moderate
"Not medically necessary" Enhanced clinical justification, ER visit records Moderate

Success rates based on appeal outcomes when proper documentation is provided

If Approved

Approval typically includes:

  • Coverage for 6-12 month initial supply
  • Required liver function monitoring
  • Renewal criteria (imaging showing partial response)
  • Quantity limits aligned with FDA dosing

Appeals Process

Illinois-Specific Rights

Illinois provides robust appeal protections under the Health Carrier External Review Act. Key timelines:

  • Internal appeal: Must be filed within timeframe specified in denial letter
  • External review: 30 days from final internal denial (shorter than many states)
  • Decision timeline: 45 days for standard, 72 hours for expedited

Internal Appeal Strategy

Level 1 Appeal Components:

  1. Cover letter addressing each denial reason point-by-point
  2. Enhanced documentation filling identified gaps
  3. Peer-reviewed evidence supporting Chenodal use in similar cases
  4. Cost-effectiveness argument (avoiding surgery, ER visits)

Peer-to-Peer Review: Request a clinical review with a gastroenterologist or hepatologist. Your doctor should emphasize:

  • Surgical contraindications with specific risk factors
  • Evidence-based likelihood of stone dissolution
  • Risks of untreated symptomatic gallstones

External Review Process

If internal appeals fail, Illinois residents can request external review through IDOI:

  1. File within 30 days of final internal denial
  2. Complete external review form available on IDOI website
  3. Include all documentation: denial letters, medical records, physician support
  4. Independent physician review by board-certified specialist
  5. Binding decision within 45 days

Illinois Department of Insurance Contact:

  • Phone: (877) 527-9431
  • External Review Portal: Available on IDOI website (verify current link)

Resolution and Approval Terms

Typical Approval Conditions

When approved, expect these requirements:

  • Initial authorization: 6-month supply
  • Monitoring: Monthly LFTs for first 3 months, then quarterly
  • Renewal criteria: Imaging showing partial stone dissolution by 9 months
  • Maximum duration: 24 months total treatment
  • Quantity limits: Aligned with FDA-approved dosing

Success Metrics

  • Partial response: ≥25% reduction in stone size by 9 months
  • Complete response: Stone dissolution confirmed by imaging
  • Treatment failure: No response by 12 months triggers discontinuation

What We'd Do Differently

Key Success Factors

Documentation quality matters most: Cases with explicit imaging language ("radiolucent cholesterol gallstones in well-opacifying gallbladder") approve 3x more often than those with generic "gallstones" reports.

Specialist involvement is crucial: Gastroenterologist prescriptions carry more weight than primary care requests. Include hepatology consultation if available.

Timing strategy: Submit PA before attempting to fill prescription. Retroactive approvals are harder to obtain and create pharmacy complications.

Common Mistakes to Avoid

  • Submitting without complete ursodiol trial documentation
  • Using generic surgical risk language instead of specific contraindications
  • Missing the 30-day external review deadline (shorter than most states)
  • Not requesting expedited review when clinically appropriate

Forms and Templates

Patient Phone Script for BCBS Member Services

"I need to verify prior authorization requirements for Chenodal (chenodiol) for gallstone treatment. Can you confirm if this drug requires PA on my plan and provide the correct forms? I also need the formulary tier and any step therapy requirements."

Clinical Documentation Template

Medical Necessity Letter Structure:

  1. Patient demographics and diagnosis
  2. Clinical presentation and symptom severity
  3. Imaging findings with explicit stone characterization
  4. Surgical contraindications with specialist assessment
  5. Prior therapy trials with specific outcomes
  6. Treatment plan with monitoring schedule
  7. Expected outcomes and success metrics

Counterforce Health helps patients and clinicians navigate complex prior authorization processes like this one. Their platform analyzes denial letters and creates targeted, evidence-backed appeals that significantly improve approval rates for specialty medications like Chenodal.

FAQ

How long does BCBS Illinois PA take for Chenodal? Standard review is 72 hours; expedited review is 24 hours if delay could seriously harm your health. Complex cases may take longer if additional information is requested.

What if Chenodal is non-formulary on my plan? Request a formulary exception using the physician exception form. Include documentation showing medical necessity and why formulary alternatives aren't appropriate.

Can I request expedited appeal in Illinois? Yes, if waiting for standard review could seriously jeopardize your health or ability to regain function. Your doctor must certify the urgent need.

Does step therapy apply if I tried ursodiol outside Illinois? Yes, prior therapy trials from other states count. Provide complete documentation including dates, doses, duration, and outcomes.

What happens if external review denies coverage? External review decisions are binding in Illinois. Consider manufacturer assistance programs or discuss alternative treatments with your gastroenterologist.

How much does Chenodal cost without insurance? Pricing varies by strength and pharmacy. Contact Travere Therapeutics for patient assistance program information and current pricing.

Can I appeal if I have Medicaid through BCBS Illinois? Yes, Medicaid managed care plans must follow similar appeal processes, with additional state fair hearing rights available.

What documentation do I need for external review? All denial letters, complete medical records, physician support letter, and the IDOI external review form. Submit within 30 days of final internal denial.

Coverage at a Glance

Requirement What It Means Where to Find It Timeline
Prior Authorization Required for most BCBS IL plans Member portal, formulary 72 hours standard
Step Therapy Must try ursodiol first Plan documents 6+ month trial typically required
Medical Necessity Radiolucent stones, surgical risk FDA labeling, policy Must document clearly
Appeals Deadline 30 days for external review Denial letter, IDOI website Shorter than most states

When working with Counterforce Health, patients receive personalized guidance through each step of this process, from initial PA preparation through external review if needed. Their expertise in payer-specific workflows helps ensure nothing falls through the cracks during what can be a complex approval journey.

Sources and Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. Appeal rights and processes may vary by plan type and can change. Verify current requirements with your insurer and the Illinois Department of Insurance.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.